CSPC Pharmaceutical Group Limited (CSPCY)

USD 2.34

(0.43%)

Total Debt Summary of CSPC Pharmaceutical Group Limited

CSPC Pharmaceutical Group Limited's latest annual total debt in 2023 was 706.9 Million CNY , up 21.35% from previous year.
CSPC Pharmaceutical Group Limited's latest quarterly total debt in 2023 FY was 706.9 Million CNY , up 21.35% from previous quarter.
CSPC Pharmaceutical Group Limited reported annual total debt of 582.54 Million CNY in 2022, up 519.44% from previous year.
CSPC Pharmaceutical Group Limited reported annual total debt of 94.04 Million CNY in 2021, down -70.31% from previous year.
CSPC Pharmaceutical Group Limited reported quarterly total debt of - CNY for 2023 Q1, down -100.0% from previous quarter.
CSPC Pharmaceutical Group Limited reported quarterly total debt of 415.26 Million CNY for 2023 Q2, down 0.0% from previous quarter.

Annual Total Debt Chart of CSPC Pharmaceutical Group Limited (2023 - 2003)

Historical Annual Total Debt of CSPC Pharmaceutical Group Limited (2023 - 2003)

Year	Total Debt	Total Debt Growth
2023	706.9 Million CNY	21.35%
2022	582.54 Million CNY	519.44%
2021	94.04 Million CNY	-70.31%
2020	316.71 Million CNY	68.88%
2019	187.53 Million CNY	0.0%
2018	- HKD	0.0%
2017	- HKD	0.0%
2016	- HKD	0.0%
2015	- HKD	0.0%
2014	- HKD	0.0%
2013	- HKD	0.0%
2012	- HKD	-100.0%
2011	279.76 Million HKD	56.12%
2010	179.19 Million HKD	0.0%
2009	- HKD	0.0%
2008	- HKD	0.0%
2007	- HKD	0.0%
2006	- HKD	0.0%
2005	- HKD	0.0%
2004	- HKD	0.0%
2003	- HKD	0.0%

Year	Total Debt	Total Debt Growth
2023 FY	706.9 Million CNY	21.35%
2023 Q1	- CNY	-100.0%
2023 Q2	415.26 Million CNY	0.0%
2023 Q3	- CNY	-100.0%
2023 Q4	706.9 Million CNY	0.0%
2022 Q2	682.56 Million CNY	0.0%
2022 Q4	582.54 Million CNY	0.0%
2022 FY	582.54 Million CNY	519.44%
2021 Q4	94.04 Million CNY	0.0%
2021 FY	94.04 Million CNY	-70.31%
2021 Q2	154.5 Million CNY	0.0%
2020 FY	316.71 Million CNY	68.88%
2020 Q2	289.34 Million CNY	0.0%
2020 Q4	316.71 Million CNY	0.0%
2019 Q2	261.88 Million CNY	0.0%
2019 FY	187.53 Million CNY	0.0%
2019 Q4	187.53 Million CNY	0.0%
2018 Q2	- HKD	0.0%
2018 FY	- HKD	0.0%
2018 Q4	- HKD	0.0%
2017 Q4	- HKD	0.0%
2017 Q2	- HKD	0.0%
2017 FY	- HKD	0.0%
2016 FY	- HKD	0.0%
2016 Q2	- HKD	0.0%
2016 Q4	- HKD	0.0%
2015 Q4	- HKD	0.0%
2015 Q2	- HKD	0.0%
2015 FY	- HKD	0.0%
2014 FY	- HKD	0.0%
2014 Q4	- HKD	0.0%
2014 Q2	- HKD	0.0%
2013 Q2	- HKD	0.0%
2013 Q4	- HKD	0.0%
2013 FY	- HKD	0.0%
2012 FY	- HKD	-100.0%
2012 Q4	- HKD	0.0%
2012 Q2	- HKD	0.0%
2011 FY	279.76 Million HKD	56.12%
2011 Q2	- HKD	0.0%
2011 Q4	279.76 Million HKD	0.0%
2010 Q4	179.19 Million HKD	0.0%
2010 FY	179.19 Million HKD	0.0%
2010 Q2	- HKD	0.0%
2009 Q4	- HKD	0.0%
2009 FY	- HKD	0.0%
2008 FY	- HKD	0.0%
2007 FY	- HKD	0.0%
2006 FY	- HKD	0.0%
2005 FY	- HKD	0.0%
2004 FY	- HKD	0.0%
2003 FY	- HKD	0.0%

Peer Total Debt Comparison of CSPC Pharmaceutical Group Limited

Name	Total Debt	Total Debt Difference
AstraZeneca PLC	28.58 Billion USD	97.527%
Bristol-Myers Squibb Company PFD CONV 2	41.46 Billion USD	98.295%
CSPC Pharmaceutical Group Limited	99.64 Million USD	-609.412%
Clarus Therapeutics Holdings, Inc.	42.26 Million USD	-1572.386%
Novartis AG	26.34 Billion USD	97.317%
PT Kalbe Farma Tbk.	40.4 Million USD	-1649.505%